10/05/2015 - 1:33pm

So far in 2015, there have bee 221,200 new cases of lung cancer and 158,040 deaths from the illness, according to the National Cancer Institute.

10/05/2015 - 1:17pm

Help2Heal represents the kind of cause marketing effort that catches the eye of the millennial shopper. According to a Nielsen survey, more than 55% of consumers globally are willing to spend more for products making a social or economic impact, and more than half of those respondents were millennials.

10/05/2015 - 12:40pm

The New York Times outlines the impact price increases of Valeant Pharmaceutical's Cuprimine has on one family, juxtaposing Valeant's pharmaceutical business model against the threat of government action. “Cuprimine is just one of many Valeant drugs whose prices have spiked as part of the company’s concerted strategy, which has richly rewarded its investors and made it one of Wall Street’s most popular health stocks,” the article said. “But Valeant’s habit of buying up existing drugs and raising prices aggressively, rather than trying to develop new drugs, has also drawn the ire of lawmakers and helped stoke public outrage against the growing trend of higher and higher drug prices imposed by big drug companies.” (New York Times)



10/05/2015 - 12:22pm

Overall, 22% of consumers who are enabling their health management through technology in 2015 vs. 13% two years ago.

10/02/2015 - 12:12pm

The company will oversee the drug’s sale, marketing and distribution in the U.S. after acquiring the rights from Pragma Pharmaceuticals. 

10/02/2015 - 12:05pm

The pharmaceutical company is donating thousands of its Evzio auto-injectors ahead of a planned Oct. 4 Washington, D.C. rally for recognizing and treating opioid addiction.

10/02/2015 - 10:36am

Skincare company eos, known for its egg-shaped lip balm, announced recently that it reached a settlement with OraLabs, a private-label manufacturer that had been selling off-brand egg-shaped lip balm.

10/02/2015 - 9:30am

Bayer HealthCare Pharmaceuticals has appointed new president with more than 20 years of experience at the company. 

10/01/2015 - 3:40pm

Tussionex has launched its generic of Tussionex, taking over marketing and distribution from Par Pharmaceuticals after Par's rights to the drug expire.